ArticleMolecular therapy oncolytics2021

Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma.

Tiangen Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.